Covid-19 Impact on Global mRNA Treatment Market Size, Status and Forecast 2020-2026

June 2020 | 99 pages | ID: C0FF6BD9982AEN
QYResearch

Abstracts

mRNA Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global mRNA Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the mRNA Treatment market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyzes the impact of Coronavirus COVID-19 on the mRNA Treatment industry.
The key players covered in this study

• CureVac
• Moderna
• BioNTech (Pfizer)
• Sanofi (Translate Bio)
• Ethris (AstraZeneca)
• Kernal Biologics
• RaNA Therapeutics
• Silence Therapeutics

Market segment by Type, the product can be split into

• Vaccine
• Drugs

Market segment by Application, split into

• Protein Diseases
• Gene Dysfunction Diseases
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global mRNA Treatment status, future forecast, growth opportunity, key market and key players.
• To present the mRNA Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

To strategically profile the key players and comprehensively analyze their development plan and strategies.

• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of mRNA Treatment are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by mRNA Treatment Revenue
1.4 Covid-19 Implications on Market by Type
  1.4.1 Global mRNA Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Vaccine
  1.4.3 Drugs
1.5 Market by Application
  1.5.1 Global mRNA Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Protein Diseases
  1.5.3 Gene Dysfunction Diseases
  1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): mRNA Treatment Industry Impact
  1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
  1.6.2 Covid-19 Impact: Commodity Prices Indices
  1.6.3 Covid-19 Impact: Global Major Government Policy
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS

2.1 Covid-19 Implications on Global mRNA Treatment Market Perspective (2015-2026)
2.2 Covid-19 Implications on Global mRNA Treatment Growth Trends by Regions
  2.2.1 mRNA Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 mRNA Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 mRNA Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 mRNA Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key mRNA Treatment Players (Opinion Leaders)

3 COVID-19 IMPLICATIONS ON COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top mRNA Treatment Players by Market Size
  3.1.1 Global Top mRNA Treatment Players by Revenue (2015-2020)
  3.1.2 Global mRNA Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global mRNA Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global mRNA Treatment Market Concentration Ratio
  3.2.1 Global mRNA Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by mRNA Treatment Revenue in 2019
3.3 mRNA Treatment Key Players Head office and Area Served
3.4 Key Players mRNA Treatment Product Solution and Service
3.5 Date of Enter into mRNA Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 COVID-19 IMPLICATIONS ON MARKET SIZE BY TYPE (2015-2026)

4.1 Global mRNA Treatment Historic Market Size by Type (2015-2020)
4.2 Global mRNA Treatment Forecasted Market Size by Type (2021-2026)

5 COVID-19 IMPLICATIONS ON MARKET SIZE BY APPLICATION (2015-2026)

5.1 Global mRNA Treatment Market Size by Application (2015-2020)
5.2 Global mRNA Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA IMPACT OF COVID-19

6.1 North America mRNA Treatment Market Size (2015-2020)
6.2 mRNA Treatment Key Players in North America (2019-2020)
6.3 North America mRNA Treatment Market Size by Type (2015-2020)
6.4 North America mRNA Treatment Market Size by Application (2015-2020)

7 EUROPE IMPACT OF COVID-19

7.1 Europe mRNA Treatment Market Size (2015-2020)
7.2 mRNA Treatment Key Players in Europe (2019-2020)
7.3 Europe mRNA Treatment Market Size by Type (2015-2020)
7.4 Europe mRNA Treatment Market Size by Application (2015-2020)

8 CHINA IMPACT OF COVID-19

8.1 China mRNA Treatment Market Size (2015-2020)
8.2 mRNA Treatment Key Players in China (2019-2020)
8.3 China mRNA Treatment Market Size by Type (2015-2020)
8.4 China mRNA Treatment Market Size by Application (2015-2020)

9 JAPAN IMPACT OF COVID-19

9.1 Japan mRNA Treatment Market Size (2015-2020)
9.2 mRNA Treatment Key Players in Japan (2019-2020)
9.3 Japan mRNA Treatment Market Size by Type (2015-2020)
9.4 Japan mRNA Treatment Market Size by Application (2015-2020)

10 SOUTHEAST ASIA IMPACT OF COVID-19

10.1 Southeast Asia mRNA Treatment Market Size (2015-2020)
10.2 mRNA Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia mRNA Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia mRNA Treatment Market Size by Application (2015-2020)

11 INDIA IMPACT OF COVID-19

11.1 India mRNA Treatment Market Size (2015-2020)
11.2 mRNA Treatment Key Players in India (2019-2020)
11.3 India mRNA Treatment Market Size by Type (2015-2020)
11.4 India mRNA Treatment Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA IMPACT OF COVID-19

12.1 Central & South America mRNA Treatment Market Size (2015-2020)
12.2 mRNA Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America mRNA Treatment Market Size by Type (2015-2020)
12.4 Central & South America mRNA Treatment Market Size by Application (2015-2020)

13KEY PLAYERS PROFILES

13.1 CureVac
  13.1.1 CureVac Company Details
  13.1.2 CureVac Business Overview and Its Total Revenue
  13.1.3 CureVac mRNA Treatment Introduction
  13.1.4 CureVac Revenue in mRNA Treatment Business (2015-2020))
  13.1.5 CureVac Recent Development and Reaction to COVID-19
13.2 Moderna
  13.2.1 Moderna Company Details
  13.2.2 Moderna Business Overview and Its Total Revenue
  13.2.3 Moderna mRNA Treatment Introduction
  13.2.4 Moderna Revenue in mRNA Treatment Business (2015-2020)
  13.2.5 Moderna Recent Development and Reaction to COVID-19
13.3 BioNTech (Pfizer)
  13.3.1 BioNTech (Pfizer) Company Details
  13.3.2 BioNTech (Pfizer) Business Overview and Its Total Revenue
  13.3.3 BioNTech (Pfizer) mRNA Treatment Introduction
  13.3.4 BioNTech (Pfizer) Revenue in mRNA Treatment Business (2015-2020)
  13.3.5 BioNTech (Pfizer) Recent Development and Reaction to COVID-19
13.4 Sanofi (Translate Bio)
  13.4.1 Sanofi (Translate Bio) Company Details
  13.4.2 Sanofi (Translate Bio) Business Overview and Its Total Revenue
  13.4.3 Sanofi (Translate Bio) mRNA Treatment Introduction
  13.4.4 Sanofi (Translate Bio) Revenue in mRNA Treatment Business (2015-2020)
  13.4.5 Sanofi (Translate Bio) Recent Development and Reaction to COVID-19
13.5 Ethris (AstraZeneca)
  13.5.1 Ethris (AstraZeneca) Company Details
  13.5.2 Ethris (AstraZeneca) Business Overview and Its Total Revenue
  13.5.3 Ethris (AstraZeneca) mRNA Treatment Introduction
  13.5.4 Ethris (AstraZeneca) Revenue in mRNA Treatment Business (2015-2020)
  13.5.5 Ethris (AstraZeneca) Recent Development and Reaction to COVID-19
13.6 Kernal Biologics
  13.6.1 Kernal Biologics Company Details
  13.6.2 Kernal Biologics Business Overview and Its Total Revenue
  13.6.3 Kernal Biologics mRNA Treatment Introduction
  13.6.4 Kernal Biologics Revenue in mRNA Treatment Business (2015-2020)
  13.6.5 Kernal Biologics Recent Development and Reaction to COVID-19
13.7 RaNA Therapeutics
  13.7.1 RaNA Therapeutics Company Details
  13.7.2 RaNA Therapeutics Business Overview and Its Total Revenue
  13.7.3 RaNA Therapeutics mRNA Treatment Introduction
  13.7.4 RaNA Therapeutics Revenue in mRNA Treatment Business (2015-2020)
  13.7.5 RaNA Therapeutics Recent Development and Reaction to COVID-19
13.8 Silence Therapeutics
  13.8.1 Silence Therapeutics Company Details
  13.8.2 Silence Therapeutics Business Overview and Its Total Revenue
  13.8.3 Silence Therapeutics mRNA Treatment Introduction
  13.8.4 Silence Therapeutics Revenue in mRNA Treatment Business (2015-2020)
  13.8.5 Silence Therapeutics Recent Development and Reaction to COVID-19

14ANALYST'S VIEWPOINTS/CONCLUSIONS

15APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. mRNA Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by mRNA Treatment Revenue
Table 3. Ranking of Global Top mRNA Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global mRNA Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Vaccine
Table 6. Key Players of Drugs
Table 7. COVID-19 Impact Global Market: (Four mRNA Treatment Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for mRNA Treatment Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for mRNA Treatment Players to Combat Covid-19 Impact
Table 12. Global mRNA Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global mRNA Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global mRNA Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global mRNA Treatment Market Share by Regions (2015-2020)
Table 16. Global mRNA Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global mRNA Treatment Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. mRNA Treatment Market Growth Strategy
Table 22. Main Points Interviewed from Key mRNA Treatment Players
Table 23. Global mRNA Treatment Revenue by Players (2015-2020) (Million US$)
Table 24. Global mRNA Treatment Market Share by Players (2015-2020)
Table 25. Global Top mRNA Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in mRNA Treatment as of 2019)
Table 26. Global mRNA Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players mRNA Treatment Product Solution and Service
Table 29. Date of Enter into mRNA Treatment Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global mRNA Treatment Market Size by Type (2015-2020) (Million US$)
Table 32. Global mRNA Treatment Market Size Share by Type (2015-2020)
Table 33. Global mRNA Treatment Revenue Market Share by Type (2021-2026)
Table 34. Global mRNA Treatment Market Size Share by Application (2015-2020)
Table 35. Global mRNA Treatment Market Size by Application (2015-2020) (Million US$)
Table 36. Global mRNA Treatment Market Size Share by Application (2021-2026)
Table 37. North America Key Players mRNA Treatment Revenue (2019-2020) (Million US$)
Table 38. North America Key Players mRNA Treatment Market Share (2019-2020)
Table 39. North America mRNA Treatment Market Size by Type (2015-2020) (Million US$)
Table 40. North America mRNA Treatment Market Share by Type (2015-2020)
Table 41. North America mRNA Treatment Market Size by Application (2015-2020) (Million US$)
Table 42. North America mRNA Treatment Market Share by Application (2015-2020)
Table 43. Europe Key Players mRNA Treatment Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players mRNA Treatment Market Share (2019-2020)
Table 45. Europe mRNA Treatment Market Size by Type (2015-2020) (Million US$)
Table 46. Europe mRNA Treatment Market Share by Type (2015-2020)
Table 47. Europe mRNA Treatment Market Size by Application (2015-2020) (Million US$)
Table 48. Europe mRNA Treatment Market Share by Application (2015-2020)
Table 49. China Key Players mRNA Treatment Revenue (2019-2020) (Million US$)
Table 50. China Key Players mRNA Treatment Market Share (2019-2020)
Table 51. China mRNA Treatment Market Size by Type (2015-2020) (Million US$)
Table 52. China mRNA Treatment Market Share by Type (2015-2020)
Table 53. China mRNA Treatment Market Size by Application (2015-2020) (Million US$)
Table 54. China mRNA Treatment Market Share by Application (2015-2020)
Table 55. Japan Key Players mRNA Treatment Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players mRNA Treatment Market Share (2019-2020)
Table 57. Japan mRNA Treatment Market Size by Type (2015-2020) (Million US$)
Table 58. Japan mRNA Treatment Market Share by Type (2015-2020)
Table 59. Japan mRNA Treatment Market Size by Application (2015-2020) (Million US$)
Table 60. Japan mRNA Treatment Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players mRNA Treatment Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players mRNA Treatment Market Share (2019-2020)
Table 63. Southeast Asia mRNA Treatment Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia mRNA Treatment Market Share by Type (2015-2020)
Table 65. Southeast Asia mRNA Treatment Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia mRNA Treatment Market Share by Application (2015-2020)
Table 67. India Key Players mRNA Treatment Revenue (2019-2020) (Million US$)
Table 68. India Key Players mRNA Treatment Market Share (2019-2020)
Table 69. India mRNA Treatment Market Size by Type (2015-2020) (Million US$)
Table 70. India mRNA Treatment Market Share by Type (2015-2020)
Table 71. India mRNA Treatment Market Size by Application (2015-2020) (Million US$)
Table 72. India mRNA Treatment Market Share by Application (2015-2020)
Table 73. Central & South America Key Players mRNA Treatment Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players mRNA Treatment Market Share (2019-2020)
Table 75. Central & South America mRNA Treatment Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America mRNA Treatment Market Share by Type (2015-2020)
Table 77. Central & South America mRNA Treatment Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America mRNA Treatment Market Share by Application (2015-2020)
Table 79. CureVac Company Details
Table 80. CureVac Business Overview
Table 81. CureVac Product
Table 82. CureVac Revenue in mRNA Treatment Business (2015-2020) (Million US$)
Table 83. CureVac Recent Development
Table 84. Moderna Company Details
Table 85. Moderna Business Overview
Table 86. Moderna Product
Table 87. Moderna Revenue in mRNA Treatment Business (2015-2020) (Million US$)
Table 88. Moderna Recent Development
Table 89. BioNTech (Pfizer) Company Details
Table 90. BioNTech (Pfizer) Business Overview
Table 91. BioNTech (Pfizer) Product
Table 92. BioNTech (Pfizer) Revenue in mRNA Treatment Business (2015-2020) (Million US$)
Table 93. BioNTech (Pfizer) Recent Development
Table 94. Sanofi (Translate Bio) Company Details
Table 95. Sanofi (Translate Bio) Business Overview
Table 96. Sanofi (Translate Bio) Product
Table 97. Sanofi (Translate Bio) Revenue in mRNA Treatment Business (2015-2020) (Million US$)
Table 98. Sanofi (Translate Bio) Recent Development
Table 99. Ethris (AstraZeneca) Company Details
Table 100. Ethris (AstraZeneca) Business Overview
Table 101. Ethris (AstraZeneca) Product
Table 102. Ethris (AstraZeneca) Revenue in mRNA Treatment Business (2015-2020) (Million US$)
Table 103. Ethris (AstraZeneca) Recent Development
Table 104. Kernal Biologics Company Details
Table 105. Kernal Biologics Business Overview
Table 106. Kernal Biologics Product
Table 107. Kernal Biologics Revenue in mRNA Treatment Business (2015-2020) (Million US$)
Table 108. Kernal Biologics Recent Development
Table 109. RaNA Therapeutics Company Details
Table 110. RaNA Therapeutics Business Overview
Table 111. RaNA Therapeutics Product
Table 112. RaNA Therapeutics Revenue in mRNA Treatment Business (2015-2020) (Million US$)
Table 113. RaNA Therapeutics Recent Development
Table 114. Silence Therapeutics Business Overview
Table 115. Silence Therapeutics Product
Table 116. Silence Therapeutics Company Details
Table 117. Silence Therapeutics Revenue in mRNA Treatment Business (2015-2020) (Million US$)
Table 118. Silence Therapeutics Recent Development
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global mRNA Treatment Market Share by Type: 2020 VS 2026
Figure 2. Vaccine Features
Figure 3. Drugs Features
Figure 4. Global mRNA Treatment Market Share by Application: 2020 VS 2026
Figure 5. Protein Diseases Case Studies
Figure 6. Gene Dysfunction Diseases Case Studies
Figure 7. Others Case Studies
Figure 8. mRNA Treatment Report Years Considered
Figure 9. Global mRNA Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global mRNA Treatment Market Share by Regions: 2020 VS 2026
Figure 11. Global mRNA Treatment Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global mRNA Treatment Market Share by Players in 2019
Figure 14. Global Top mRNA Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in mRNA Treatment as of 2019
Figure 15. The Top 10 and 5 Players Market Share by mRNA Treatment Revenue in 2019
Figure 16. North America mRNA Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe mRNA Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China mRNA Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan mRNA Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia mRNA Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India mRNA Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America mRNA Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. CureVac Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. CureVac Revenue Growth Rate in mRNA Treatment Business (2015-2020)
Figure 25. Moderna Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Moderna Revenue Growth Rate in mRNA Treatment Business (2015-2020)
Figure 27. BioNTech (Pfizer) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. BioNTech (Pfizer) Revenue Growth Rate in mRNA Treatment Business (2015-2020)
Figure 29. Sanofi (Translate Bio) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Sanofi (Translate Bio) Revenue Growth Rate in mRNA Treatment Business (2015-2020)
Figure 31. Ethris (AstraZeneca) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Ethris (AstraZeneca) Revenue Growth Rate in mRNA Treatment Business (2015-2020)
Figure 33. Kernal Biologics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Kernal Biologics Revenue Growth Rate in mRNA Treatment Business (2015-2020)
Figure 35. RaNA Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. RaNA Therapeutics Revenue Growth Rate in mRNA Treatment Business (2015-2020)
Figure 37. Silence Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Silence Therapeutics Revenue Growth Rate in mRNA Treatment Business (2015-2020)
Figure 39. Bottom-up and Top-down Approaches for This Report
Figure 40. Data Triangulation
Figure 41. Key Executives Interviewed